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______________________

Introduction: The treatment of pelvic malignancies with radiotherapy can develop severe sequelae, especially radiation-induced hemorrhagic cystitis. It is a progressive
disease that can lead to the need for blood transfusion, hospitalizations, and surgical
interventions. This tends to affect the quality of life of these patients, and management
can at times be difficult. We have evaluated the GreenLight Xcelerated Performance
System (XPS) with TruCoag, although primarily used for management of benign prostatic hypertrophy (BPH), for the treatment of radiation-induced hemorrhagic cystitis.
Materials and Methods: After International Review Board (IRB) approval, a retrospective chart review was performed in addition to a literature search. A series of four male
patients, mean age of 81 years, with radiation-induced hemorrhagic cystitis secondary
to radiotherapy for pelvic malignancies (3 prostate cancer, 1 rectal cancer) were successfully treated with the GreenLight laser after unsuccessful treatment with current
therapies described in the literature.
Results: All four patients treated with the GreenLight laser had resolution of their
hematuria after one treatment and were discharge from the hospital with clear urine.
Conclusion: The GreenLight XPS laser shows promising results for the treatment of
patients with radiation-induced hemorrhagic cystitis, and deserves further evaluation
and validation, especially since there is limited data available in the literature regarding the use of this technology for the treatment of this devastating condition.
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INTRODUCTION
The treatment of radiation-induced hemorrhagic cystitis can be especially frustrating for
the practicing urologist. This potentially severe
condition can appear more than 10 years after pelvic radiotherapy (1). Among patients treated with
external beam pelvic radiotherapy or brachytherapy, 2.1% to 8.2% will have symptomatic hematuria, which can result in repeat hospital admissions,
require blood transfusions, and surgical interventions for necessary treatment (2). Historically,
treatments have included bladder irrigation with
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evacuation of clots and fulguration with electro-cautery, oral and intravesical agents, hyperbaric
oxygen, and ultimately cystectomy with urinary
diversion (Table-1). These treatments have been
successful to varying degrees in the past. One potential endoscopic treatment is the use of laser technology for coagulation of the bladder.
Over the last several years, there have been
significant advances in laser technology. Since first
introduced in 1992, the laser has been mainly utilized in prostatic ablation and stone surgery. The
initial Neodymium: Yttrium-Aluminum-Garnet
(Nd: YAG), with its wavelength of 1064nm, had an
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Table 1 - Management options for the treatment of intractable
hemorrhagic cystitis.
Large Bore Catheter Drainage
Bladder Irrigation with Saline/Water
- Intermittent
- Continuous
Cystoscopy/Clot Evacuation/Fulguration
-Monopolar Electro cautery
-Bipolar Electro cautery
Hyperbaric Oxygen
Bladder Instillation
-Alum

postulate that this technology would be of benefit
in treating patients with refractory hemorrhagic
cystitis. To our knowledge, after an extensive literature search, there have been no reports of its
usage in the treatment of radiation-induced hemorrhagic cystitis.
We present our initial series of patients,
after retrospective chart review, which underwent
successful GreenLight laser therapy for radiation-induced hemorrhagic cystitis. We demonstrate
that novel use of this technology may benefit patients with this difficult problem.
MATERIALS AND METHODS

-1% Silver Nitrate
-Formalin
GreenLight™ Laser Ablation/Fulguration
Selective Bladder Angioembolization
Cystectomy and Urinary Diversion

excellent coagulation effect, but with significant
absorption of energy into the tissue causing irritative post-procedural symptoms secondary to the
sloughing of necrotic tissue (3). With the addition
of the potassium-titanyl-phosphate (KTP) crystal
the wavelength was reduced in half with more immediate and efficient vaporization of tissue, with
Malek et al. introducing its use for photo selective
vaporization of the prostate for benign prostatic
hyperplasia (BPH) in 1998 (4). The application of
the KTP laser has expanded beyond prostatic ablation surgery, including, but not limited to, urethral
hemangiomas and even partial nephrectomies in
human and animal models (5, 6). The GreenLight™
laser (American Medical Systems® (AMS); Minnetonka, MN) is capable of producing a coagulation
effect by either defocusing the beam or reducing
power. Most recently, the GreenLight™ Xcelerated
Performance System (XPS) with TruCoag™ has
been developed by AMS. The improved coagulation effect of this laser has expanded the potential
uses of this technology.
It is a combination of this improved coagulation effect with minimal depth of penetration;
the wavelength of 1064nm is ideal for lysing red
blood cells, and the fact that the GreenLight laser
has no contact, minimizing any additional trauma to the already friable tissue, that has led us to

Patients
After International Review Board (IRB) approval, a retrospective chart review was performed
at the James A. Haley Veterans’ Affairs Hospital in
Tampa, FL. Patients treated for hemorrhagic cystitis, most commonly, but not limited to, radiation-induced between January 2010 and June 2012.
These patients must first have been treated with
current standard of care, and then treated with the
GreenLight laser after unsuccessful treatment with
current therapies as described in the literature.
The algorithm of treatment, at this institution, involves first management with large bore
catheters and intermittent/continuous bladder irrigations. If this fails, cystoscopy with clot evacuation and fulguration is then utilized. Once the
patients have required more than one trip to the
operating room (in a 3 month period of time) for
management of their hemorrhagic cystitis, they
are started on hyperbaric oxygen therapy, and are
considered for bladder instillations. If unsuccessful, or if the patient prefers not to proceed with
bladder instillations, prior to considering angioembolization/surgical intervention, they are given
the option of proceeding with GreenLight laser
ablation/fulguration of the bladder.
After reviewing 100 charts, we identified
four male patients who presented to the emergency room with gross hematuria and were subsequently admitted to the hospital for management
of their hematuria. The average patient age was
81 years and all had a history of external beam
radiation therapy. Three patients underwent radio-
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therapy for prostate cancer and one patient for
rectal cancer. All had previously undergone a full
clinical evaluation for their hematuria which was
noted to be negative for upper or lower tract pathology. Each patient had been noted on cystoscopy to have evidence of hemorrhagic cystitis and
had previously been treated with cystoscopy, clot
evacuation, and at least one round of fulguration
using electro-cautery with subsequent recurrence
of their hematuria.
Surgical Technique
The procedure was performed under general anesthesia with the patient in the low dorsal lithotomy position. A rigid 22 French cystoscope was utilized to evacuate the bladder of all
clots and a complete cystoscopy was performed to
identify the source of bleeding and rule out any
other unidentified pathology. The GreenLight laser
was used to target any active source of bleeding,
as well as any prominent telangiectatic vessels
of the irradiated mucosa perceived as a potential
source of future bleeding. These areas were coagulated with the laser at a setting of 40 watts with
the laser fiber 3-4mm from the tissue. The vaporization setting was not used for this procedure.
Throughout the procedure, saline irrigation was
used and care was taken to ensure that the ureteral
orifices were not injured. At the completion of the
procedure, the bladder was drained under direct
visualization to ensure adequate hemostasis. Very
minimal bladder mucosal damage was appreciated. Then, a large three-way catheter was placed
and continuous irrigation was maintained overnight and stopped the next morning.
RESULTS
All four patients successfully underwent
coagulation with the GreenLight laser system.
They were able to be discharged home with clear
urine. One patient had urinary retention and mild
recurrence of his hematuria on attempted catheter removal, which was solely managed by placement of a Foley catheter. The other three patients
successfully underwent catheter removal without
difficulty. None of the patients have required subsequent hospitalization or surgical procedures for

management of their radiation cystitis in a mean
follow-up of 12 months.
DISCUSSION
Traditionally, the treatment of patients
with radiation-induced hemorrhagic cystitis has
been a difficult and frustrating experience, especially because of the progressive ischemic nature
of the radiation injury on the bladder mucosa. This
can result in multiple hospital admissions with a
significant financial expense. Multiple therapies
have been utilized in the past with varying degrees of success, with hyperbaric oxygen showing the
most promising results (7), but it requires several
treatments with substantial cost and has limited
availability.
The GreenLight laser has become one of
the standards in prostatic ablative therapy. Multiple studies have been performed investigating the
usage of this technology for the management of
BPH (8-10). Its use in the treatment of radiation-induced hemorrhagic cystitis has not yet been
described. The previously poor coagulation effect
of the GreenLight™ laser limited its use in this regard. Thus, the advent of the GreenLight™ XPS
system with TruCoag™ has opened up the realm
of potential alternative uses, including the treatment of radiation-induced hemorrhagic cystitis.
The non-contact nature of this laser, improved
coagulation effect, and its wavelength of 1064nm
(lysing red blood cells), all make this technology
ideal for management of this very frustrating disease.
We acknowledge that this series is limited
by the small sample size and its retrospective nature. However, the initial series of patients treated
at our institution does demonstrate the potential
use of this technology. While adjunct therapies
such as hyperbaric oxygen may still be required
in the long term, the short-term results and potential for decreased hospitalizations is promising.
Further investigation of the GreenLight laser for
radiation-induced hemorrhagic cystitis is necessary to determine the long-term viability of this
treatment. At our institution, we have begun the
prospective evaluation of this treatment.
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CONCLUSION

4.

Chronic hematuria secondary to radiation
cystitis can be difficult to treat. Often times, a
multidisciplinary approach is necessary. We have
evaluated another indication for the GreenLight
laser in the management of radiation-induced hemorrhagic cystitis refractory to current standard
of care therapy. It is possible to perform this procedure, using minimally invasive technology, in a
safe and efficient manner. It may be used in conjunction with other treatment modalities, and may
also be incorporated as a bridge to more definitive
therapy, including hyperbaric oxygen therapy. The
KTP laser is a recent addition to the urologist’s armamentarium in treating BPH, and now we have
successfully treated refractory hematuria.
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